Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4.99M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
87.9M
-
Shares change
-
-16.8M
-
Total reported value, excl. options
-
$30.3M
-
Value change
-
-$35.8M
-
Put/Call ratio
-
0.8
-
Number of buys
-
51
-
Number of sells
-
-80
-
Price
-
$0.34
Significant Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q1 2025
165 filings reported holding MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.9M shares
.
Largest 10 shareholders include Nextech Invest, Ltd. (12.1M shares), Bain Capital Life Sciences Investors, LLC (8.66M shares), VANGUARD GROUP INC (8.38M shares), BlackRock, Inc. (8.33M shares), Schonfeld Strategic Advisors LLC (7.61M shares), AQR CAPITAL MANAGEMENT LLC (5.14M shares), Rock Springs Capital Management LP (3.81M shares), VR ADVISER, LLC (3.57M shares), SILVERARC CAPITAL MANAGEMENT, LLC (3.09M shares), and ACADIAN ASSET MANAGEMENT LLC (2.99M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.